FindTrial
Sign In

A Real World Study for Direct Antiviral Drugs in the treatment of patients with Chronic Hepatitis C and cirrhosis

A Real World Study for Direct Antiviral Drugs in the treatment of patients with Chronic Hepatitis C and cirrhosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023747
Enrollment
Unknown
Registered
2019-06-10
Start date
2017-12-01
Completion date
Unknown
Last updated
2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic hepatitis C

Interventions

Case series:Direct antiviral drugs

Sponsors

Tianjin Third Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Chronic hepatitis C patients with HCV RNA positive; 2. Patients treated with DAA.

Exclusion criteria

Exclusion criteria: 1. Patients who cannot follow up regularly according to doctor's advice; 2. Patients with interferon therapy.

Design outcomes

Primary

MeasureTime frame
HCVRNA;ALT;;—

Countries

China

Contacts

Public ContactLiang Jing

Tianjin Third Central Hospital

haolele77@sina.com+86 13163135596

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026